- Neuroendocrine Cancer
- Resources
- Join Us For a Cure
- Research
- About Us
Patients and Clinicians: I urge you to read the following important announcement about clinical trials.
This announcement is from the Neuroendocrine Task Force (NTF). I am a patient advocate on this national task force. The NTF's membership comprises the leading clinicians and scientists in the neuroendocrine field.
The main point is of the announcement is:
The NTF supports clinical trials with angiogensis inhibitors in neuroendocrine tumors.
Please contact me with any questions.
nancy.ohagan@caringforcarcinoid.org

Post new comment